ClinicalTrials.gg
RecruitingNCT07787845NESTUpdated Oct 23, 2026

The Goal is to Examine the Impact of Doula-delivered, Nurse-coordinated Postpartum Care Among Individuals With Preterm Births <34 Weeks' Gestation Requiring NICU Admission.

An interventional study of Doula-delivered, Nurse-coordinated postpartum support in Doula Support, Postpartum and Postpartum Depression (PPD), sponsored by University of South Carolina. Recruiting at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-23.

Sponsored by University of South Carolina · Not applicable, Interventional, and Prevention

Updated Oct 23, 2026Now RecruitingSite recruiting status changed+3 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
350
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

The primary objective of this research is to conduct a randomized clinical trial to examine the impact of nurse-coordinated, doula-delivered postpartum support (intervention arm) on postpartum health care utilization, health outcomes, and patient-reported experiences compared with standard postpartum care (control arm) among individuals with preterm births \<34 weeks' gestation requiring neonatal intensive care unit (NICU) admission.

Read the detailed description

This study will employ a randomized controlled trial design. Participants will be recruited from Prisma Health Richland Hospital and may be enrolled during late pregnancy (including individuals on bed rest), in a postpartum unit, or while their infant is admitted to the NICU. Inclusion criteria will be English speaking individuals ≥18 years old on Medicaid insurance, who delivered a baby \<34 weeks' gestation, and whose baby will be admitted to the NICU. The control arm of the trial will receive standard postpartum care, while the intervention arm will receive doula postpartum support and nurse-coordinated postpartum care, mental health screening and referral, and consistent follow-up for iron deficiency anemia.

02

Conditions studied

  • Doula Support
  • Postpartum
  • Postpartum Depression (PPD)
  • Postpartum Anemia

Keywords

  • preterm
  • doula support
  • mental health
03

In context

Depression, Postpartum

569 studies on the registry are indexed under Depression, Postpartum; 134 are open to participants now.

This study's planned enrollment of 350 is above the median of 104 across 454 interventional studies indexed under Depression, Postpartum.

Browse Depression, Postpartum studies →

Lead sponsor

University of South Carolina is the lead sponsor of 197 studies on the registry; 42 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age above 18 at time of delivery of infant
  • English-speaking
  • Medicaid insurance coverage at the time of delivery, either as primary or secondary coverage
  • Delivery before 34 weeks' gestation
  • Infant admitted to the NICU, 10 days old or less

Exclusion criteria

Exclusion Criteria:

  • Stillbirth
  • Infant death in the delivery room
  • Infant with severe congenital anomalies expected to result in death shortly after birth
  • Inability to provide
  • Inability to visit the infant in the NICU at least once per week
  • More than 10 days postpartum
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
350 participants (estimated)

Study arms

  • No intervention
    Control

    Participants will receive routine postpartum care by their regular OB provider office and will fill remotely questionnaires at 6 months regarding mental health and breastfeeding practices.

  • Experimental
    Intervention

    Participants will receive at least weekly doula support while their newborn(s)/ infant(s) is/are admitted in the NICU, for a minimum of 3 visits. Participants will have the option to receive routine postpartum care through their regular OB provider office or by the nurse associated with the study on NICU premises before going back to their regular OB provider. They will remotely fill a mental health questionnaire at 3 months and questionnaires at 6 months regarding mental health, breastfeeding practices, and satisfaction with the program.

    Behavioral: Doula-delivered, Nurse-coordinated postpartum support

Interventions

  • BehavioralDoula-delivered, Nurse-coordinated postpartum support

    Doulas offer continuous emotional and physical support, which can help reduce stress and improve mental health outcomes. Nurses bring specialized knowledge in maternal and newborn care, ensuring that medical and psychosocial needs are addressed holistically. Together, doulas and nurses can enhance the quality of postpartum care, promote maternal well-being, and potentially reduce the incidence of SMM and mortality. This integrated approach can also facilitate better coordination of care and support for birthing individuals.

06

What researchers measure

Primary outcomes

  1. Rate of receipt of postpartum care within 2 weeks of delivery

    Time frame: From delivery of infant(s) to 2 weeks postpartum

  2. Rate of receipt of postpartum care within 6 weeks of delivery

    Time frame: From delivery of infant(s) to 6 weeks postpartum

Secondary outcomes

  1. Time to receipt of postpartum care visit within 6 weeks postpartum

    Time frame: From delivery of infant(s) to 6 weeks postpartum

  2. Number of outpatient visits within 6 months postpartum

    Time frame: From delivery of infant(s) to 6 months postpartum

  3. Rate of postpartum depression at 6 months postpartum

    Measured using the Edinburgh Postnatal Depression Scale (EPDS)

    Time frame: At 6 months postpartum

  4. Rate of post-traumatic stress disorder (PTSD) symptoms at 6 months postpartum

    Measured using the PTSD Checklist for DSM-5 (PCL-5)

    Time frame: At 6 months postpartum

  5. Rate of milk expression/breastfeeding initiation

    Time frame: At 6 months postpartum

  6. Duration of exclusive breastfeeding

    Time frame: At 6 months postpartum

  7. Rate of treatment for iron deficiency anemia in the intervention group

    Participants whose last hemoglobin (Hb) measurement during the delivery hospitalization was \<10 g/dL will undergo repeat Hb assessment at approximately 2 weeks postpartum. Participants with a postpartum Hb \<9 g/dL will undergo iron studies to evaluate for iron deficiency. Management of iron deficiency anemia, including oral or intravenous iron therapy as clinically indicated, will be provided in accordance with current clinical guidelines and the treating clinician's judgment.

    Time frame: From delivery of infant(s) up to 6 weeks postpartum

  8. Rate of emergency department visits within 12 months postpartum

    Time frame: At 1 year postpartum

  9. Rate of postpartum readmissions within 12 months postpartum

    Time frame: At 1 year postpartum

  10. Average daily expressed breastmilk volume in the NICU in the first 7, 14, or 28 days

    Time frame: 7, 14, 28 days

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2026 (actual). Primary completion is estimated for Aug 2029, 34 months after the start.

Of 256 non-industry interventional studies with no phase under Depression, Postpartum, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 36. This study's planned 34 months is above that.

Counting every sponsor, half of 262 studies reached it within 23 months; a quarter within 11 and three quarters within 36.

Start moved once since we started tracking on Sep 25, 2026: Sep 2026 → Oct 2026, on Oct 23, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Aug 19, 2026
First posted
Aug 26, 2026
StartActual
Oct 21, 2026was Sep 2026
Primary completionEst.
Aug 2029
CompletionEst.
Aug 2030
Last update
Oct 23, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Oct 23, 2026
Sites
Prisma Health Richland is now Recruiting
Oct 23, 2026
Start date
Sep 2026→Oct 21, 2026 (actual)
Oct 23, 2026
Interventions
Added Behavioral: Doula-delivered, Nurse-coordinated postpartum support; removed Behavioral: Doula-coordinated, Midwife-delivered postpartum care
Oct 23, 2026
Title
The Goal is to Examine the Impact of Doula-coordinateddelivered, MidwifeNurse-deliveredcoordinated Postpartum Care Among Individuals With Preterm Births <34 Weeks' Gestation Requiring NICU Admission.
Oct 23, 2026
Show all 1 update
  1. Oct 23, 2026
    Not yet recruiting→Recruiting
    Prisma Health Richland is now Recruiting
    Start date Sep 2026→Oct 21, 2026 (now actual)
    Interventions Added Behavioral: Doula-delivered, Nurse-coordinated postpartum support; removed Behavioral: Doula-coordinated, Midwife-delivered postpartum care
    Title The Goal is to Examine the Impact of Doula-coordinateddelivered, MidwifeNurse-deliveredcoordinated Postpartum Care Among Individuals With Preterm Births <34 Weeks' Gestation Requiring NICU Admission.
    + 3 other changes: verification date, description and conditions

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07787845
Collaborators
Prisma Health-Midlands
Responsible party
Nansi Boghossian (Associate Professor, University of South Carolina) — Principal investigator
First posted
Aug 26, 2026
Start date
Oct 21, 2026
Primary completion
Aug 2029 (estimated)
Completion
Aug 2030 (estimated)
Last update
Oct 23, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion